Loading data
CCLDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 120.5 m USD | 110.84 m USD | 117.06 m USD | 138.83 m USD | 139.6 m USD |
| Research and development expense | 6.38 m USD | 3.78 m USD | 4.74 m USD | 4.4 m USD | 4.41 m USD |
| Operating profit | 11.34 m USD | 9.12 m USD | -47.12 m USD | 6.61 m USD | 3.53 m USD |
| Profit before tax | 11 m USD | 8.01 m USD | -49.04 m USD | 5.61 m USD | 2.99 m USD |
| Income tax expense | 199 k USD | 160 k USD | -364 k USD | 177 k USD | 157 k USD |
| Net income (reported basis) | 10.8 k USD | 7.85 k USD | -48.67 k USD | 5.43 m USD | 2.84 m USD |
| Net income attributable to common shareholders | 3.89 m USD | -4.46 m USD | -64.35 m USD | -10.09 m USD | -11.22 m USD |
| Basic earnings per share | 0.1 USD/share | -0.28 USD/share | -4.11 USD/share | -0.67 USD/share | -0.77 USD/share |
| Diluted earnings per share | 0.1 USD/share | -0.28 USD/share | -4.11 USD/share | -0.67 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.